SCHEMBL8984229

SCHEMBL8984229

O=C1CN=C(C(F)(F)F)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8371275 0.76 MEN1 (0.30)
SCHEMBL6699179 0.66 TSHR (0.35)
SCHEMBL1751894 0.62
SCHEMBL8623854 0.60
SCHEMBL6703126 0.60 TSHR (0.30)
SCHEMBL6695075 0.60 TSHR (0.30)
SCHEMBL12146398 0.57
SCHEMBL6699288 0.57
SCHEMBL6699597 0.57
SCHEMBL966568 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5541080-A SOLVOLYSIS WITH METHANOL IN PRESENCE OF A LIPASE IN NON-POLAR SOLVENT FOLLOWED BY ENANTIOSELECTIVELY CLEAVING ESTER WITH A PROTEASE WISCONSIN ALUMNI RESEARCH FDN. (US) 1996-07-30 US disclosed
EP-0400499-B1 Medicine containing acylaminoacid derivatives and dietetic products KALI CHEMIE AG (DE) 1994-04-06 EP disclosed
EP-0400499-A2 Medicine containing acylaminoacid derivatives and dietetic products Kali-Chemie Aktiengesellschaft (DE) 1990-12-05 EP disclosed